Coan E J, Collingridge G L
Br J Pharmacol. 1987 Jul;91(3):547-56. doi: 10.1111/j.1476-5381.1987.tb11248.x.
The effects of representative drugs from three classes of psychotomimetic compounds (arylcyclohexylamines, benzomorphan opioids and dioxolanes) have been examined on synaptic transmission at an identified monosynaptic pathway in rat hippocampal slices. The compounds tested were phencyclidine (PCP) and ketamine, the racemate and isomers of SKF 10,047 (N-allylnormetazocine), and the isomers of dioxadrol (dexoxadrol and levoxadrol). In the absence of added magnesium ions (Mg) in the perfusion medium low frequency stimulation of the Schaffer collateral-commissural pathway evoked a burst of population spikes in the CA1 cell body region. The secondary components of this response could be abolished by the selective N-methyl-D-aspartate (NMDA) antagonist D-2-amino-5-phosphonovalerate (APV). PCP (1 microM) or ketamine (10 microM) selectively blocked the secondary components of the synaptic response. The effect of PCP was neither mimicked nor prevented by hexamethonium and atropine, phentolamine and propranolol, or clonidine and was therefore unlikely to involve cholinergic or adrenergic neurotransmitter systems. The sigma opiate, (+/-)-SKF 10,047 (10 microM) also abolished selectively the secondary components of the synaptic response. There was no apparent difference between the potency of the stereoisomers of this compound. The action of (+/-)-SKF 10,047 was not affected by either naloxone or haloperidol, indicating that this effect did not involve opioid receptors or the haloperidol-sensitive sigma site. Dexoxadrol (10 microM), but not levoxadrol (10 microM), also selectively blocked the secondary components of the synaptic response. It is concluded that these psychotomimetic agents can block an NMDA receptor-mediated component of synaptic transmission in the hippocampus and that this effect is mediated by a specific PCP/sigma site.
已对三类拟精神病化合物(芳基环己胺、苯吗喃类阿片和二氧戊环)中的代表性药物对大鼠海马切片中一条已确定的单突触通路的突触传递的影响进行了研究。所测试的化合物有苯环己哌啶(PCP)和氯胺酮、SKF 10,047(N -烯丙基去甲左啡诺)的外消旋体和异构体,以及二氧达罗(右二氧达罗和左二氧达罗)的异构体。在灌注介质中不添加镁离子(Mg)的情况下,对海马伞 - 连合通路进行低频刺激会在CA1细胞体区域诱发一阵群体峰电位。该反应的次级成分可被选择性N -甲基 - D -天冬氨酸(NMDA)拮抗剂D - 2 -氨基 - 5 -磷酸戊酸(APV)消除。PCP(1微摩尔)或氯胺酮(10微摩尔)选择性阻断突触反应的次级成分。六甲铵和阿托品、酚妥拉明和普萘洛尔、可乐定均不能模拟或阻止PCP的作用,因此其作用不太可能涉及胆碱能或肾上腺素能神经递质系统。σ阿片样物质(±)-SKF 10,047(10微摩尔)也选择性地消除了突触反应的次级成分。该化合物的立体异构体在效力上没有明显差异。(±)-SKF 10,047的作用不受纳洛酮或氟哌啶醇的影响,表明这种作用不涉及阿片受体或氟哌啶醇敏感的σ位点。右二氧达罗(10微摩尔),而非左二氧达罗(10微摩尔),也选择性阻断突触反应的次级成分。得出的结论是,这些拟精神病药物可阻断海马中NMDA受体介导的突触传递成分,且这种作用是由特定的PCP/σ位点介导的。